Jobs / United States / Astrazeneca Pharmaceuticals Lp
Senior Director, USMA Business Planning
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Location: Gaithersburg, MD (3 days per week) The Lead/Head, USMA Business Planning is a senior strategic leadership role that owns and drives the broader finance and planning cycle for US Medical Affairs (USMA), shaping how the organization plans, prioritizes and executes against enterprise strategy. The role owns the integrated USMA business planning capability (iMAP) – unifying strategy, medical plans, initiatives, resources, budgets, payments and milestones into a single operating model – and gives CIME and USMA leadership one consolidated, decision-ready view of the portfolio and the actions required to advance it. Working directly with the Finance Director, the Lead/Head coordinates the key forums that govern the USMA planning cycle — including the franchise forums — and independently owns the agendas, milestones, timelines, due dates and organizational scorecard that keep USMA aligned and on track. The Lead/Head builds and leads a future-fit, AI-enabled SPM and Business Specialist organization in partnership with the CIME Innovation team, and works as a trusted strategic partner to the Head of CIME, the USMA Vice President, Franchise Heads, the Finance Director, Commercial OLT Business Planning Leads and GMA MESO leadership. This is an elevated, enterprise-facing role that combines strategic influence, senior people leadership and hands-on portfolio ownership across a complex, matrixed medical organization — with the expectation that the Lead/Head independently leads the USMA finance and planning cycle and the integrated medical planning process end-to-end, rather than simply supporting it. Key responsibilities • Strategic portfolio leadership: Own and continuously evolve the integrated USMA business planning capability (iMAP), independently translating enterprise strategy into an integrated portfolio, annual plans, milestones and measures, and positioning USMA as a model for future-fit medical planning. • SPM leadership: Lead, elevate and develop the franchise/function-aligned SPM organization, carrying direct accountability for driving — in a clear and consistent way — the integrated USMA medical planning process across the team; set strategic objectives and standards, allocate work against enterprise priorities, manage performance, and build capability and succession for the next generation of SPM talent. • Business Specialist leadership: Lead the USMA Operations Manager and the Business Specialist organization, including oversight of purchase orders, invoicing and budget rephasing in Anaplan, ensuring consistent, high-quality operational services and development across the team. • Flexible capacity deployment: Assess demand and capacity across the SPM and Business Specialist teams and flexibly deploy or rebalance support against business priority, workload and risk, while building deep Tumor expertise across the Project Manager book of work. • Governance and planning rhythm: Independently own and drive the USMA planning rhythm and decision-making forums — including coordinating the franchise forums — setting and managing the agendas, milestones, timelines, due dates and the USMA organizational scorecard, and establishing common platforms, lexicon, governance, standards, tools, dashboards, tracking and escalation routes across every TA Franchise. • Finance and planning cycle ownership: Own and drive the broader USMA finance and planning cycle end-to-end, working directly with the Finance Director. Lead the Mid-Term Planning (MTP) process from start to finish — consolidating inputs across franchises and functions, generating insights, and reviewing and challenging the outputs with the relevant functional leaders — and partner with the USMA Vice President to build the USMA narrative for MTP and Reporting Business U